Cargando…
Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
The complexity of Alzheimer’s disease (AD) and its long prodromal phase poses challenges for early diagnosis and yet allows for the possibility of the development of disease modifying treatments for secondary prevention. It is, therefore, of importance to develop biomarkers, in particular, in the pr...
Autores principales: | Baird, Alison L., Westwood, Sarah, Lovestone, Simon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4644785/ https://www.ncbi.nlm.nih.gov/pubmed/26635716 http://dx.doi.org/10.3389/fneur.2015.00236 |
Ejemplares similares
-
A Decade of Blood Biomarkers for Alzheimer’s Disease Research: An Evolving Field, Improving Study Designs, and the Challenge of Replication
por: Shi, Liu, et al.
Publicado: (2018) -
Blood biomarkers for Alzheimer’s disease
por: Lovestone, Simon
Publicado: (2014) -
Predicting AT(N) pathologies in Alzheimer’s disease from blood-based proteomic data using neural networks
por: Zhang, Yuting, et al.
Publicado: (2022) -
The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer’s pathology
por: Westwood, Sarah, et al.
Publicado: (2017) -
Plasma Proteomic Biomarkers Relating to Alzheimer’s Disease: A Meta-Analysis Based on Our Own Studies
por: Shi, Liu, et al.
Publicado: (2021)